IL123922A - Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp - Google Patents

Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp

Info

Publication number
IL123922A
IL123922A IL12392297A IL12392297A IL123922A IL 123922 A IL123922 A IL 123922A IL 12392297 A IL12392297 A IL 12392297A IL 12392297 A IL12392297 A IL 12392297A IL 123922 A IL123922 A IL 123922A
Authority
IL
Israel
Prior art keywords
ruminants
prevention
detection
treatment
effective amount
Prior art date
Application number
IL12392297A
Other languages
English (en)
Original Assignee
Dale Wallis
James L Wallis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dale Wallis, James L Wallis filed Critical Dale Wallis
Publication of IL123922A publication Critical patent/IL123922A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
IL12392297A 1996-08-01 1997-07-31 Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp IL123922A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2291596P 1996-08-01 1996-08-01

Publications (1)

Publication Number Publication Date
IL123922A true IL123922A (en) 2005-07-25

Family

ID=21812090

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12392297A IL123922A (en) 1996-08-01 1997-07-31 Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp

Country Status (19)

Country Link
US (2) US6162429A (fr)
EP (1) EP0863981B1 (fr)
JP (1) JP2000500027A (fr)
KR (1) KR19990063786A (fr)
CN (1) CN1198185A (fr)
AT (1) ATE443755T1 (fr)
AU (1) AU732317B2 (fr)
BR (1) BR9706543A (fr)
CA (1) CA2233570C (fr)
DE (1) DE69739592D1 (fr)
DK (1) DK0863981T3 (fr)
EA (2) EA004873B1 (fr)
ES (1) ES2336285T3 (fr)
IL (1) IL123922A (fr)
MX (1) MX9802543A (fr)
NZ (1) NZ330050A (fr)
PT (1) PT863981E (fr)
TR (1) TR199800597T1 (fr)
WO (1) WO1998005755A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6667040B2 (en) 1997-09-08 2003-12-23 University Technologies International, Inc. Bovine footrot treatment and prevention
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US7097861B1 (en) 2003-02-07 2006-08-29 Jones-Hamilton Co. Method of treating livestock footbath solutions
US8703104B2 (en) * 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175516A (en) * 1966-04-15 1969-12-23 Science Union & Cie New Phenyl-Aminopropane Derivatives and Preparations Containing them
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
US4029763A (en) 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5630379A (en) * 1996-02-12 1997-05-20 Ssi Corporation Electrically controlled spraying device for cleaning and treating animals
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
CN1198185A (zh) 1998-11-04
NZ330050A (en) 2000-01-28
ATE443755T1 (de) 2009-10-15
MX9802543A (es) 1998-11-30
US6884412B1 (en) 2005-04-26
CA2233570A1 (fr) 1998-02-12
EA200001056A1 (ru) 2001-04-23
WO1998005755A1 (fr) 1998-02-12
DE69739592D1 (de) 2009-11-05
KR19990063786A (ko) 1999-07-26
PT863981E (pt) 2010-01-04
TR199800597T1 (xx) 1998-06-22
CA2233570C (fr) 2013-02-19
EP0863981A1 (fr) 1998-09-16
EA199800243A1 (ru) 1998-10-29
AU3809997A (en) 1998-02-25
ES2336285T3 (es) 2010-04-09
US6162429A (en) 2000-12-19
EP0863981B1 (fr) 2009-09-23
EA004873B1 (ru) 2004-08-26
AU732317B2 (en) 2001-04-12
BR9706543A (pt) 1999-12-28
EP0863981A4 (fr) 2002-09-18
DK0863981T3 (da) 2010-02-01
JP2000500027A (ja) 2000-01-11
EA002181B1 (ru) 2002-02-28

Similar Documents

Publication Publication Date Title
HUT75555A (en) Lactobacillus strains of human origin, their compositions and uses thereof
BG100960A (en) Dosage forms for controlled release of azitromycin
EP1032417A4 (fr) Vaccins bacteriens contenant des souches auxotrophes attenuees de listeria exprimant des antigenes heterologues
WO2001082788A3 (fr) Traitement et prevention d'infections bacteriennes et composes a cet effet
GB9621091D0 (en) Attenuated microorganisms strains and their uses
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
AU6040001A (en) Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
BG102818A (en) D-manitol and method for its preparation
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
UA32542C2 (uk) Спосіб безперервного зволоження сипких харчових продуктів і кормів та пристрій для його здійснення
IL123922A (en) Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp
SI0716852T1 (en) Pharmaceutical formulations of cefaclor
SE9603725D0 (sv) New teatment
CA2064029A1 (fr) Utilisation de mycobacterium vaccae dans la prevention du sida
IL116275A0 (en) Methods for obtaining strains of trichoderma spp. and strains obtained thereby
BG102667A (en) Diosgenine-containing composition
EP1037918A4 (fr) Procede et composition pour ameliorer l'efficacite d'un vaccin
EP1303300A4 (fr) Compositions et procedes de traitement de la candidiase
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
MD916G2 (ro) Unguent pentru tratamentul afecţiunilor dentare
MD980129A (en) Antiherpetic remedy
NZ326769A (en) High-content famciclovir tablets
WO2005004791A3 (fr) Composes et procedes de traitement et de prevention d'infections bacteriennes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees